MRNA: Moderna, Inc. Stock

by  •  • Comments Off on MRNA: Moderna, Inc. Stock

SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)

Valuation
Market Cap ($M) 41,676.45
Enterprise Value ($M) 38,769.45
Book Value ($M) 13,854.00
Book Value / Share 36.18
Price / Book 3.01
NCAV ($M) 5,753.00
NCAV / Share 15.03
Price / NCAV 7.24

Profitability (mra)
Return on Invested Capital (ROIC) -0.31
Return on Assets (ROA) -0.20
Return on Equity (ROE) -0.25

Liquidity (mrq)
Quick Ratio 3.36
Current Ratio 3.42

Balance Sheet (mrq) ($M)
Current Assets 10,325.00
Assets 18,426.00
Liabilities 4,572.00
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 6,848.00
Operating Income -4,239.00
Net Income -4,714.00
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -3,118.00
Cash from Investing 4,206.00
Cash from Financing -1,377.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
04-10 13G/A Vanguard Group Inc 10.20 15.13
02-07 13G/A Bancel Stephane 7.80 4.23
01-29 13G/A BlackRock Inc. 6.60 -3.12
01-29 13G/A Baillie Gifford & Co 11.97 1.94

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-02-23 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-K
2023-11-03 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q
2023-08-03 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q
2023-05-04 10-Q Form 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-04-25 556,103 2,312,720 24.05
2024-04-24 574,901 2,811,885 20.45
2024-04-23 375,837 883,382 42.55
2024-04-22 437,998 1,067,651 41.02

(click for more detail)

Similar Companies
MIST – Milestone Pharmaceuticals Inc. MLYS – Mineralys Therapeutics, Inc.
MNMD – Mind Medicine (MindMed) Inc. MRSN – Mersana Therapeutics, Inc.
MRVI – Maravai LifeSciences Holdings, Inc.


Financial data and stock pages provided by
Fintel.io